top of page
Executive Spotlights

Chiesi to Buy Amryt for $1.5 Billion in Rare Disease Expansion

Cary, NC, January 8, 2023 (Bloomberg) -- Chiesi Farmaceutici SpA agreed to buy Amryt Pharma Plc for as much as $1.48 billion to expand its portfolio of medicines that treat rare diseases.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page